Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $1.66 in the prior trading day, Alx Oncology Holdings Inc (NASDAQ: ALXO) closed at $1.67, up 0.60%. In other words, the price has increased by $0.60 from its previous closing price. On the day, 0.64 million shares were traded. ALXO stock price reached its highest trading level at $1.708 during the session, while it also had its lowest trading level at $1.56.
Ratios:
Our goal is to gain a better understanding of ALXO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on December 19, 2024, Downgraded its rating to Hold and sets its target price to $2 from $12 previously.
On March 08, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also upped its target price recommendation from $10 to $14.
Jefferies Upgraded its Hold to Buy on December 08, 2023, whereas the target price for the stock was revised from $8 to $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Hemrajani Rekha bought 30,000 shares for $1.55 per share. The transaction valued at 46,404 led to the insider holds 33,000 shares of the business.
Pinto Shelly sold 564 shares of ALXO for $1,455 on Aug 14 ’24. The SVP, FINANCE AND CAO now owns 91,549 shares after completing the transaction at $2.58 per share. On Aug 14 ’24, another insider, Randolph Sophia, who serves as the CHIEF MEDICAL OFFICER of the company, sold 1,365 shares for $2.58 each. As a result, the insider received 3,522 and left with 325,711 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 88080976 and an Enterprise Value of -43135016.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is 10.18%, while the 200-Day Moving Average is calculated to be -72.51%.
Shares Statistics:
The stock has traded on average 956.81K shares per day over the past 3-months and 1504540 shares per day over the last 10 days, according to various share statistics. A total of 52.74M shares are outstanding, with a floating share count of 34.33M. Insiders hold about 34.92% of the company’s shares, while institutions hold 58.48% stake in the company. Shares short for ALXO as of 1734048000 were 8394637 with a Short Ratio of 8.77, compared to 1731628800 on 7225229. Therefore, it implies a Short% of Shares Outstanding of 8394637 and a Short% of Float of 27.58.
